Evidence map›Paper›PMID 33480174›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2021

Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease.

Hong-Dong Li, Cory C Funk, Karen McFarland, Eric B Dammer, Mariet Allen, Minerva M Carrasquillo, Yona Levites, Paramita Chakrabarty, Jeremy D Burgess, Xue Wang and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Truncated Tau caused by intron retention is enriched in Alzheimer's disease cortex and exhibits altered biochemical properties.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 2 countries.

Hong-Dong LiHunan Provincial Key Lab on Bioinformatics, School of Computer Science and Engineering, Central South University, Changsha, Hunan, P.R. China.
Cory C FunkInstitute for Systems Biology, Seattle, Washington, USA.
Karen McFarlandDepartment of Neuroscience and Neurology, Center for Translational Research in Neurodegenerative disease, and McKnight Brain Institute, University of Florida, Gainesville, Florida, USA.
Eric B DammerDepartment of Biochemistry, Emory University, Atlanta, Georgia, USA.
Mariet AllenMayo Clinic, Department of, Neuroscience, Jacksonville, Florida, USA.
Minerva M CarrasquilloMayo Clinic, Department of, Neuroscience, Jacksonville, Florida, USA.
Yona LevitesDepartment of Neuroscience and Neurology, Center for Translational Research in Neurodegenerative disease, and McKnight Brain Institute, University of Florida, Gainesville, Florida, USA.
Paramita ChakrabartyDepartment of Neuroscience and Neurology, Center for Translational Research in Neurodegenerative disease, and McKnight Brain Institute, University of Florida, Gainesville, Florida, USA.
Jeremy D BurgessMayo Clinic, Department of, Neuroscience, Jacksonville, Florida, USA.
Xue WangMayo Clinic, Department of Health Sciences Research, Jacksonville, Florida, USA.
Dennis DicksonMayo Clinic, Department of, Neuroscience, Jacksonville, Florida, USA.
Nicholas T SeyfriedDepartment of Biochemistry, Emory University, Atlanta, Georgia, USA.
Duc M DuongDepartment of Biochemistry, Emory University, Atlanta, Georgia, USA.
James J LahDepartment of Neurology, Emory University, Atlanta, Georgia, USA.
Steven G YounkinMayo Clinic, Department of, Neuroscience, Jacksonville, Florida, USA.
Allan I LeveyDepartment of Neurology, Emory University, Atlanta, Georgia, USA.
Gilbert S OmennInstitute for Systems Biology, Seattle, Washington, USA.
Nilüfer Ertekin-TanerMayo Clinic, Department of, Neuroscience, Jacksonville, Florida, USA.
Todd E GoldeDepartment of Neuroscience and Neurology, Center for Translational Research in Neurodegenerative disease, and McKnight Brain Institute, University of Florida, Gainesville, Florida, USA.
Nathan D PriceInstitute for Systems Biology, Seattle, Washington, USA.
Emory University · USJacksonville College · USUniversity of Florida · USInstitute for Systems Biology · USMayo Clinic in Florida · USCentral South University · CNUniversity of Michigan–Ann Arbor · US

Funding

Vascular Structure and Function in Cognitive AgingP01AG003949 · NIA · YESHIVA UNIVERSITY · PI Richard B. LIPTON · 1985 to 2026
$73.9M
SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI PETERSEN, RONALD C · 1999 to 2018
$36.9M
Research Education ComponentP30AG019610 · NIA · SUN HEALTH RESEARCH INSTITUTE · PI REIMAN, ERIC MICHAEL · 2001 to 2020
$32.5M
The Emory Alzheimer's Disease CenterP50AG025688 · NIA · EMORY UNIVERSITY · PI WINGO, THOMAS SPURGEON · 2005 to 2019
$25.7M
Integrating the exposome and methylome to inform brain molecular changes in ADRD across established diverse cohorts.U01AG046139 · NIA · UNIVERSITY OF FLORIDA · PI ERTEKIN-TANER, NILUFER, FUNK, CORY · 2013 to 2022
$24.6M
Strategic Vision & Impact on Environmental HealthP30ES017885 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Dana Dolinoy · 2011 to 2026
$21.3M
TRANSGENIC MODELING OF TAUOPATHYP01AG017216 · NIA · MAYO CLINIC JACKSONVILLE · PI DICKSON, DENNIS WILLIAM · 1999 to 2011
$12.0M
Integrative translational discovery of vascular risk factors in aging and dementiaRF1AG051504 · NIA · MAYO CLINIC JACKSONVILLE · PI BU, GUOJUN, ERTEKIN-TANER, NILUFER · 2015 to 2019
$9.8M
Discovery of Novel Proteomic Targets in Alzheimer's DiseaseU01AG046161 · NIA · EMORY UNIVERSITY · PI BENNETT, DAVID ALAN, GESCHWIND, DANIEL H · 2014 to 2018
$8.4M
PREDICTORS OF THE RATE OF COGNITIVE DECLINE IN ELDERLY SUBJECTSP50AG025711 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI POTTER, HUNTINGTON · 2005 to 2010
$8.2M
National Brain and Tissue Resource for Parkinson's Disease and Related DisordersU24NS072026 · NINDS · BANNER SUN HEALTH RESEARCH INSTITUTE · PI BEACH, THOMAS G · 2011 to 2015
$7.8M
NCI NIH HHS U24 CA210967NIA NIH HHS P01 AG003949NIA NIH HHS P01 AG017216NIA NIH HHS P30 AG019610NIA NIH HHS P50 AG016574NIA NIH HHS P50 AG025688NIA NIH HHS P50 AG025711NIA NIH HHS R01 AG018023NIA NIH HHS R01 AG032990NIA NIH HHS R01 AG061796NIA NIH HHS RF1 AG051504NIA NIH HHS U01 AG006786NIA NIH HHS U01 AG046139NIA NIH HHS U01 AG046161NIEHS NIH HHS P30 ES017885NINDS NIH HHS R01 NS080820NINDS NIH HHS U24 NS072026
6 · The paper itself

Abstract

Intron retention (IR) has been implicated in the pathogenesis of complex diseases such as cancers; its association with Alzheimer's disease (AD) remains unexplored. We performed genome-wide analysis of IR through integrating genetic, transcriptomic, and proteomic data of AD subjects and mouse models from the Accelerating Medicines Partnership-Alzheimer's Disease project. We identified 4535 and 4086 IR events in 2173 human and 1736 mouse genes, respectively. Quantitation of IR enabled the identification of differentially expressed genes that conventional exon-level approaches did not reveal. There were significant correlations of intron expression within innate immune genes, like HMBOX1, with AD in humans. Peptides with a high probability of translation from intron-retained mRNAs were identified using mass spectrometry. Further, we established AD-specific intron expression Quantitative Trait Loci, and identified splicing-related genes that may regulate IR. Our analysis provides a novel resource for the search for new AD biomarkers and pathological mechanisms.

Indexed as

Alzheimer DiseaseAutopsyDisease Models, AnimalGenomicsAnimalsBrainHomeodomain ProteinsHumansIntronsMiceProteomicsQuantitative Trait LociTranscriptomeHmbox1 protein, mouseHomeodomain Proteinsalternative splicingAlzheimer's diseasegene expressionintegrative analysisintron retention

Identifiers

PMID33480174
PMCPMC8248162
OpenAlexW3124012596

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.